CHARACTERIZATION OF IMMUNE CHECKPOINT INHIBITOR-RELATED CARDIOTOXICITY IN LUNG CANCER PATIENTS FROM A RURAL SETTING IN EASTERN NORTH CAROLINA

ICI-related cardiotoxicities (iRCs) are rare however recent literature have described myocarditis, pericardial disorders, cardiomyopathies and arrhythmias as potential fatal adverse effects. The cardiotoxic profile of ICIs is not well defined. Our study aimed to characterize iRCs in lung cancer